2019
DOI: 10.1590/0001-3765201920190220 View full text |Buy / Rent full text
|
|

Abstract: Liver fibrosis is the final common pathway of chronic liver diseases, having cirrhosis as a possible progression, which has liver transplantation as the only effective treatment. Human amniotic membrane represents a potential strategy as a therapy for liver fibrosis, due to its anti-inflammatory, antifibrotic and immunomodulatory properties. The aim of this study was to evaluate amniotic membrane effects as a treatment for hepatic fibrosis induced in rats by bile duct ligation (BDL), verifying alterations betw… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
1
0

Publication Types

Select...

Relationship

0
0

Authors

Journals